查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1146382

快速動物檢測市場 - COVID-19 的增長、趨勢、影響和預測 (2022-2027)

Veterinary Rapid Test Market - Growth, Trends, and Forecasts (2022 - 2027)
出版日期: | 出版商: Mordor Intelligence | 英文 110 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內，快速動物試驗市場預計將以 8.7% 的複合年增長率增長。

在 COVID-19 大流行期間，出現了一些 SARS-CoV-2 感染病例，尤其是在與 COVID-19 感染者直接接觸的動物中。儘管 COVID-19 大流行對全球市場產生了負面影響，但隨著人們更加關注動物診斷工具的開發以識別動物疾病，快速動物試驗取得了積極增長。包括美國在內的多個國家/地區都報告了狗和貓感染 COVID-19 的病例。例如，美國農業部 (USDA) 國家獸醫服務實驗室 (NVSL) 於 2020 年 6 月發布的一份報告在紐約州的狗（德國牧羊犬）中發現 SARS-CoV-2 (COVID-19 病毒) 被確認為第一次。美國第一隻 SARS-CoV-2 檢測呈陽性的狗。同樣，根據美國農業部 (USDA) 和美國疾病控制與預防中心 (CDC) 國家獸醫服務實驗室 (NVSL) 在 2020 年 4 月的報告，兩隻寵物貓報告了 SARS-CoV-2 (COVID-19)。19病原病毒）確診感染病例。這些貓在主人的 COVID-19 檢測呈陽性後感染了病毒。例如，2021 年 11 月，路易斯安那州動物疾病診斷實驗室 (LADDL) 與路易斯安那州公共衛生部和疾病控制中心 (CDC) 合作，在 2021 年 12 月 31 日之前為路易斯安那州的狗和貓提供 COVID-19。我們已經開始了一個提供免費測試的項目。大流行期間寵物擁有量的增加也促進了市場增長。例如，根據 2021 年 6 月發布的患病動物人民醫院 (PDSA) PAW 報告，2020 年 3 月至 2021 年 5 月期間，英國有 200 萬人養了寵物。這一趨勢對 COVID-19 大流行期間的市場增長產生了積極影響。

消費者對科學動物營養意識的提高、工業化牲畜生產的增加以及對動物性蛋白質來源需求的增加是促進所研究市場增長的因素。肉類、牛奶和雞蛋是最近需求激增的食品之一。由於資源枯竭和耕地不足導致農業生產力下降，動物源性食品的消費量正在增加。動物源性食品是蛋白質的重要來源，富含蛋白質的飲食對於保持身體健康很重要。根據糧食及農業組織統計數據庫，2020年動物蛋白消費量在富裕國家穩定（44-55克/人/天），而在發展中國家消費量在增加。我知道。例如，根據 2022 年 8 月發布的美國農業部對外農業服務局的數據，到 2020 年，美國將佔全球牛肉消費量的約 21%。 2020 年，亞洲消費了 19,656,460 噸牛肉和小牛肉，預計到 2026 年將增加到 21,467,080 噸。預計農民將增加畜產品的產量，以滿足對動物性飲食日益增長的需求。牲畜疾病是造成牲畜系統中一系列問題的原因，包括生產力下降、糧食安全不安全和收入損失，並且還對人類健康產生不利影響。因此，牲畜疾病診斷測試的增加已成為推動市場增長的主要因素。

因此，上述因素共同歸因於所研究的市場在預測期內的增長。然而，預計新興國家獸醫診斷基礎設施不足將阻礙預測期內的市場增長。

主要市場趨勢

預計在預測期內快速檢測試劑盒將強勁增長

快速檢測試劑盒是經濟實惠的檢測試劑盒，易於在現場或實驗室使用，無需顯微鏡或電力。快速檢測試劑盒佔了最大的份額，它可以靈活地運行一項或多項測試，允許根據需要進行測試，做出正確的臨床決策，節省時間和金錢我認為是因為你可以。快速檢測試劑盒很方便，因為它們可以在室溫下長期保存並提供快速結果，而且這些快速檢測的特異性在 90% 到 100% 之間。另一方面，靈敏度為85%至90%。像這樣的準確測試將導致早期診斷和早期治療，從而增加該領域的需求。

根據2020年6月出版的《不丹診斷狂犬病金標準熒光抗體檢測快速免疫層析檢測試劑盒評價雜誌》，快速檢測試劑盒可用於疑似狂犬病病例的快速反應。據稱，在不丹等資源匱乏的國家，該疫苗已顯著提高了能力並減少了狂犬病在動物和人類中的進一步傳播。由於不丹尋求消除犬傳人類狂犬病，因此需要改進敏感性監測以快速識別和根除動物種群中的狂犬病病毒傳播。如此快速的診斷結果將增加對快速測試的需求並推動該領域的增長。

北美有望主導快速動物試驗市場

由於大量牲畜和人畜共患病以及寵物擁有率高，預計北美將主導市場。在 2020 年 COVID-19 大流行之後，美國和該地區的其他國家採取了非常大的措施來應對大流行病，以改善人類的醫療保健。預防性診斷工具的開發也有助於增加獸醫就診和預防保健。 2021 年 4 月，Mars Veterinary Health 旗下公司 Intech Diagnostics 公佈了對 730,000 次獸醫診所就診的回顧性審查的新數據，顯示所有貓的 RenalTech 改進預防保健檢測呈陽性或陰性。 Renaltec 預測貓慢性腎病 (CKD) 發病前 2 年。數據顯示，預測性診斷工具使獸醫診所的就診次數增加了 31%。新興國家對預測診斷工具的研發也在推動該國市場的增長。

與銷售額下降形成鮮明對比的是，洛杉磯防止虐待動物協會報告稱，2020 年 6 月，寵物動物的收養率翻了一番。據報導，每天大約有10到13隻寵物被領養。根據美國寵物用品協會 (APPA) 全國寵物主人調查 (2021-2022)，美國 70% 的家庭是寵物主人。北美寵物健康保險協會 (NAPHIA) 2021 年行業狀況報告顯示，2020 年受保寵物總數達到 310 萬，高於 2019 年的 250 萬。我來了。該報告還指出，狗仍然是主要的受保寵物，佔 82.9%，貓佔 17.1%。從長遠來看，寵物的日益流行和主人對健康的關注可能會推動快速動物試驗的發展。

因此，由於上述因素，北美地區的研究市場有望增長。

競爭格局

快速動物試驗市場在本質上是分散的，多家公司在全球和區域開展業務。競爭格局佔據市場份額，著名的 Zoetis, Inc、IDEXX Laboratories, Inc、Heska Corporation、Thermo Fisher Scientific Inc、Biopanda Reagents Ltd、Fassisi GmbH、Virbac、BioNote, Inc、SWISSAVANS AG、MEGACOR Diagnostik 包括分析多家國際和本地公司，例如 GmbH、Woodley Equipment Company。

其他福利。

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動因素
    • 人畜共患疾病的流行和發病率上升
    • 對動物源性食品的需求增加
    • 伴侶動物數量增加
  • 市場製約因素
    • 新興國家的獸醫診斷基礎設施不足
    • 飆升的寵物護理費用
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：100 萬美元）

  • 按產品分類
    • 快速測試套件
    • 快速測試閱讀器
  • 通過申請
    • 病毒性疾病
    • 細菌性疾病
    • 寄生蟲病
    • 過敏症
    • 其他用途
  • 按動物類型
    • 伴侶動物
    • 家畜
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東和非洲
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • Zoetis, Inc.
    • IDEXX Laboratories, Inc.
    • Heska Corporation
    • Thermo Fisher Scientific Inc.
    • Biopanda Reagents Ltd.
    • Fassisi GmbH
    • Virbac
    • BioNote, Inc.
    • MEGACOR Diagnostik GmbH
    • Woodley Equipment Company

第七章市場機會與未來趨勢

簡介目錄
Product Code: 92040

The veterinary rapid test market is expected to register a CAGR of 8.7% over the forecast period.

There were a few cases of SARS-CoV-2 infection in animals during the COVID-19 pandemic, especially in animals that had direct contact with COVID-19-infected people. More attention is being paid to the development of veterinary diagnostics tools for identifying diseases in animals which led to a positive growth in veterinary rapid tests despite the COVID-19 pandemic's ongoing negative effects on worldwide markets. There have been cases of COVID-19 infections in cats and dogs in a several countries, including the United States. For instance, according to a report National Veterinary Services Laboratories (NVSL) of the United States Department of Agriculture (USDA), published on June 2020, the first confirmed case of SARS-CoV-2 (the virus that causes COVID-19) infection in a pet dog (German shepherd) in the state of New York. The first dog to test positive for SARS-CoV-2 in the US. Similarly, according to the National Veterinary Services Laboratories (NVSL) of the United States Department of Agriculture (USDA) and the Centers for Disease Control and Prevention (CDC) in April 2020, announced confirmed cases of SARS-CoV-2 (the virus that causes COVID-19) infection in two pet cats. These cats got infected by the virus after their owner tested positive for COVID-19. For instance, in November 2021, the Louisiana Animal Disease Diagnostic Laboratory (LADDL) partnered with the Louisiana Office of Public Health and the Centers for Disease Control (CDC) on a project to provide free COVID-19 testing for dogs and cats in Louisiana through December 31, 2021. Also, the increasing pet adoption during the pandemic has contributed to the market's growth. For instance, according to the People's Dispensary for Sick Animals (PDSA) PAW report published in June 2021, 2 million people in the United Kingdom acquired pets between March 2020 to May 2021. This trend has positively impacted the market growth during the COVID-19 pandemic.

Increasing consumer awareness regarding scientific animal nutrition, increase in industrialized livestock production, and the increasing demand for animal-based protein sources are the factors augmenting the growth of the market studied. Meat, milk, and eggs are among the foods whose demand has surged recently. Due to declining agricultural productivity as a result of depleting resources and a shortage of cultivated land, the consumption of animal-derived foods is rising. Foods derived from animals are a key source of protein and eating a diet high in protein is crucial for maintaining good health. According to Food and Agriculture Organization Corporate Statistical Database, in 2020, animal protein consumption in wealthy nations is steady (between 44 and 55 g / capita / day), whereas consumption is rising in developing nations. For instance, according to USDA Foreign Agricultural Service, published in August 2022, the U.S. accounted for about 21% of the world's beef consumption in 2020. Asia consumed 19,656.46 thousand tons of beef and veal in 2020, and that number is projected to rise to 21,467.08 thousand tons by 2026. In order to meet the rising demand for meals derived from animals, farmers are anticipated to boost livestock production. Livestock diseases are contributing to a set of problems within the livestock production systems, including productivity losses, uncertain food security, and loss of income, adversely affecting human health. Thus, increasing diagnostic testing of livestock diseases are the major factors driving the growth of the market.

Therefore, the factors mentioned above are attributed collectively to the studied market growth over the forecast period. However inadequate veterinary diagnostics infrastructure in developing countries are expected to hinder the market growth over the forecast period.

Key Market Trends

Rapid Test Kits is Expected to Witness High Growth Over the Forecast Period

Rapid Test Kits is affordable, speedy, and easy to use in the field or laboratory setting without the need for a microscope or electricity, and it quick (5-10 minutes) results. Rapid Test Kits are found to hold the largest share which can be attributed to the flexibility to perform single or multiple tests so that the test is performed as needed to make the right clinical decisions and avoid wasted time and money. Rapid test kits are convenient to store at room temperature for an extended period of time where the results are obtained faster and the specificity of these rapid tests ranges from 90% to 100%. In comparison, sensitivity ranges from 85% to 90% in a given rapid test kit. Such accurate testing will lead to an early diagnosis and treatment which will boost the segment demand.

According to a "Journal on Evaluation of a rapid immunochromatographic test kit to the gold standard fluorescent antibody test for diagnosis of rabies in animals in Bhutan", published in June 2020, the rapid kits have significantly improved the ability to deliver a rapid response to suspected rabies cases and decreased further rabies spread in both animals and people in resource-constrained nations like Bhutan. To quickly identify and eradicate rabies virus circulation in animal populations, sensitivity surveillance must be improved as Bhutan is on the verge of eliminating dog-mediated human rabies. Such rapid diagnostic result will increase the demand of rapid test boosting the segment growth.

North America is Expected to Dominate the Veterinary Rapid Test Market

North America is expected to dominate the market owing to factors such as high prevalence of livestock animals and zoonotic diseases coupled with the rising pet ownership in the region. After the 2020 COVID-19 pandemic, the United States and other states in the region have taken extraordinary steps to cope with the pandemic situation for improved human healthcare was tremendous. The development of preventive diagnostic tools also contributes to the increasing veterinary visits and preventive care. In April 2021, Intech Diagnostics, a part of Mars Veterinary Health, released new data that shows that all cats from a retrospective review of 730,000 veterinary visits received improved preventive care following a positive or negative RenalTech. RenalTech predicts chronic kidney disease (CKD) in cats two years before it occurs. The data shows that the predictive diagnostic tool increased veterinary visits by as much as 31%. Such studies and the development of predictive diagnostics tools are also driving the market growth in the country.

In contrast to the decline in sales, as per the reports of the Society for the Prevention of Cruelty to Animals, Los Angeles, the rate of adoption of pet animals was doubled in June 2020. The report suggests daily adoptions of pet animals were about 10 to 13 per day. According to American Pet Products Association's (APPA) National Pet Owners Survey (2021-2022) 70% of households in the United States reported as pet owners. North American Pet Health Insurance Association (NAPHIA), State of the Industry Report for 2021 show the total number of pets insured in 2020 reached 3.1 million, up from 2.5 million in 2019. This report also states that dogs continue to be the major insured pets with 82.9% and cats for 17.1%. The rising adoption of pets and their health concern by the owner may drive the growth of veterinary rapid test in the longer term.

Therefore, owing to the aforesaid factors the growth of the studied market is anticipated in the North America Region.

Competitive Landscape

The veterinary rapid test market is fragmented in nature due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold the market shares and are well known include Zoetis, Inc., IDEXX Laboratories, Inc., Heska Corporation, Thermo Fisher Scientific Inc., Biopanda Reagents Ltd., Fassisi GmbH, Virbac, BioNote, Inc., SWISSAVANS AG, MEGACOR Diagnostik GmbH, and Woodley Equipment Company, among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rise in Prevalence and Incidence of Zoonotic Diseases
    • 4.2.2 Increasing Demand for Animal-Derived Food Products
    • 4.2.3 Growth in Companion Animal Population
  • 4.3 Market Restraints
    • 4.3.1 Inadequate Veterinary Diagnostics Infrastructure in Developing Countries
    • 4.3.2 High in Pet Care Cost
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Rapid Test Kits
    • 5.1.2 Rapid Test Readers
  • 5.2 By Application
    • 5.2.1 Viral Diseases
    • 5.2.2 Bacterial Diseases
    • 5.2.3 Parasitic Diseases
    • 5.2.4 Allergies
    • 5.2.5 Other Applications
  • 5.3 By Animal Type
    • 5.3.1 Companion Animals
    • 5.3.2 Livestock Animals
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Zoetis, Inc.
    • 6.1.2 IDEXX Laboratories, Inc.
    • 6.1.3 Heska Corporation
    • 6.1.4 Thermo Fisher Scientific Inc.
    • 6.1.5 Biopanda Reagents Ltd.
    • 6.1.6 Fassisi GmbH
    • 6.1.7 Virbac
    • 6.1.8 BioNote, Inc.
    • 6.1.9 MEGACOR Diagnostik GmbH
    • 6.1.10 Woodley Equipment Company

7 MARKET OPPORTUNITIES AND FUTURE TRENDS